GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bonesupport Holding AB (FRA:2B4) » Definitions » Asset Impairment Charge

Bonesupport Holding AB (FRA:2B4) Asset Impairment Charge : €0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Bonesupport Holding AB Asset Impairment Charge?

Bonesupport Holding AB's Asset Impairment Charge for the three months ended in Dec. 2024 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.


Bonesupport Holding AB Asset Impairment Charge Historical Data

The historical data trend for Bonesupport Holding AB's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bonesupport Holding AB Asset Impairment Charge Chart

Bonesupport Holding AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bonesupport Holding AB Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bonesupport Holding AB Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.


Bonesupport Holding AB Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Bonesupport Holding AB's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


Bonesupport Holding AB Business Description

Traded in Other Exchanges
Address
Scheelevagen 19, Lund, SWE, SE-223 70
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and sells injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and has the ability to release pharmaceuticals to promote healing. Its products focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: North America (NA) and Europe & Rest of the World (EUROW).

Bonesupport Holding AB Headlines

No Headlines